drugset / Trial / NCT00433576
Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This phase I trial is studying the side effects and best dose of resveratrol in treating patients with colorectal cancer that can be removed by surgery. Resveratrol may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Timeline
- Start
- 2006-12
- Primary completion
- 2008-11
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Resveratrol | Small molecule | — | Oral |